{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:34:21Z","timestamp":1760060061916,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clindermatol.2021.05.027","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T16:55:55Z","timestamp":1621616155000},"page":"674-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!"],"prefix":"10.1016","volume":"39","author":[{"given":"Christian","family":"Gronbeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.05.027_bib0001","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1038\/s41598-021-85555-1","article-title":"Vaccination strategies against COVID-19 and the diffusion of anti-vaccination views","volume":"11","author":"Prieto Curiel","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.clindermatol.2021.05.027_sbref0002","article-title":"Answers to all your questions about getting vaccinated for Covid-19","author":"Lieberman","year":"2021","journal-title":"The New York Times"},{"key":"10.1016\/j.clindermatol.2021.05.027_sbref0002a","unstructured":"https:\/\/www.nytimes.com\/interactive\/2021\/well\/covid-vaccine-questions.html. Access date: May 1, 2021"},{"key":"10.1016\/j.clindermatol.2021.05.027_sbref0003","article-title":"Had Facial Fillers? What You Need to Know About COVID Vaccines","author":"McNiff","year":"2021","journal-title":"US News & World Report"},{"key":"10.1016\/j.clindermatol.2021.05.027_sbref0003a","unstructured":"https:\/\/www.usnews.com\/news\/health-news\/articles\/2021-04-12\/had-facial-fillers-what-you-need-to-know-about-covid-vaccines. Access date: May 1, 2021"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108748","article-title":"Anaphylaxis associated with the mRNA COVID-19 vaccines: approach to allergy investigation","volume":"227","author":"Erdeljic Turk","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2021.05.027_sbref0005","article-title":"Covid-19 Vaccines Have Triggered Severe Allergic Reactions in 29 People in U.S. to Date","author":"McKay","year":"2021","journal-title":"The Wall Street Journal"},{"key":"10.1016\/j.clindermatol.2021.05.027_sbref0005a","unstructured":"https:\/\/www.wsj.com\/articles\/covid-19-vaccines-have-triggered-severe-allergic-reactions-in-29-people-in-u-s-to-date-11609956076. Access date: May 1, 2021"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases [e-pub ahead of print]","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.clindermatol.2021.04.001","article-title":"Cutaneous adverse effects of the available COVID-19 vaccines [e-pub ahead of print]","author":"Bogdano","year":"2021","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0008","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19 [e-pub ahead of print]","author":"Sadoff","year":"2021","journal-title":"N Eng J Med"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0010","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0011","unstructured":"US Department of Health and Human Services (DHHS) PHSP, Centers for Disease Control (CDC) \/Food and Drug Administration (FDA). Vaccine Adverse Event Reporting System (VAERS). Available at: http:\/\/wonder.cdc.gov\/vaers.html. Accessed April 25, 2021."},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2021.1214","article-title":"Delayed localized hypersensitivity reactions to the Moderna COVID-19 vaccine: a case series [e-pub ahead of print]","author":"Johnston","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0013","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1002\/jmv.26996","article-title":"Non-life-threatening adverse effects of COVID-19 mRNA-1273 vaccine: a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms","volume":"93","author":"Kadali","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0014","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0015","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17268","article-title":"Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 vaccine: an Italian single centre case series [e-pub ahead of print]","author":"Corbeddu","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17248","article-title":"Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine [e-pub ahead of print]","author":"Ackerman","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0018","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Available at: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html. Accessed April 25, 2021, 2021."},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0019","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine \u2014 United States, December 21, 2020\u2013January 10, 2021. Available at: https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7004e1.htm. Accessed April 25, 2021, 2021.","DOI":"10.15585\/mmwr.mm7004e1"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0020","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine \u2014 United States, December 14\u201323, 2020. Available at: https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7002e1.htm. Accessed April 25, 2021, 2021.","DOI":"10.15585\/mmwr.mm7002e1"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/all.14839","article-title":"Skin tests in urticaria\/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: limits of intradermal testing [e-pub ahead of print]","author":"Bianchi","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0022","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.anai.2021.03.012","article-title":"Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: early report","volume":"126","author":"Pitlick","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0023","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/vaccines9050412","article-title":"Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2","volume":"9","author":"Restivo","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0024","doi-asserted-by":"crossref","DOI":"10.5070\/D3271052044","article-title":"Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine","volume":"27","author":"Jedlowski","year":"2021","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.15575","article-title":"Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine [e-pub ahead of print]","author":"L\u00f3pez-Valle","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0026","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0027","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17250","article-title":"Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. \u2018COVID-arm\u2019: a clinical and histological characterization[e-pub ahead of print]","author":"Fernandez-Nieto","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27036","article-title":"Herpes zoster emergence following mRNA COVID-19 vaccine [e-pub ahead of print]","author":"Eid","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0029","article-title":"Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series [e-pub ahead of print]","author":"Furer","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0030","article-title":"A flare of pre-existing erythema multiforme post BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine [e-pub ahead of print]","author":"Nawimana","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17225","article-title":"Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination [e-pub ahead of print]","author":"Gambichler","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0032","article-title":"COVID-19\/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment\u201d [e-pub ahead of print]","author":"Munavalli","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0033","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdcr.2021.03.046","article-title":"New-onset chilblains in close temporal association to mRNA-1273 vaccination","volume":"12","author":"Kha","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0034","doi-asserted-by":"crossref","DOI":"10.1111\/ced.14673","article-title":"Ribonucleic acid COVID-19 vaccine-associated cutaneous adverse drug events: a case series of two patients [e-pub ahead of print]","author":"Lam","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17342","article-title":"Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine [e-pub ahead of print]","author":"Cyrenne","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0036","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/JBM.S307047","article-title":"Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine","volume":"12","author":"Helms","year":"2021","journal-title":"J Blood Med"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0037","first-page":"e14099","article-title":"Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine","volume":"13","author":"Malayala","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0038","doi-asserted-by":"crossref","first-page":"E133","DOI":"10.1002\/ajh.26106","article-title":"Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine","volume":"96","author":"Tarawneh","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0039","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)00623-6","article-title":"Reactivation of herpesvirus infections after vaccinations?","volume":"353","author":"Walter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdcr.2021.02.018","article-title":"Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation","volume":"10","author":"Munavalli","year":"2021","journal-title":"JAAD Case Rep"},{"article-title":"American Society for Dermatologic Surgery","year":"2019","series-title":"2019 Procedures Survey Results Infographic","key":"10.1016\/j.clindermatol.2021.05.027_sbref0041"},{"key":"10.1016\/j.clindermatol.2021.05.027_sbref0041a","unstructured":"https:\/\/www.asds.net\/portals\/0\/PDF\/procedures-survey-results-infographic-2019.pdf. April 25, 2021"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0042","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Black","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0043","article-title":"Postinfluenza vaccination idiopathic thrombocytopenic purpura in three elderly patients","volume":"2016","author":"Nagasaki","year":"2016","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.clindermatol.2021.05.027_bib0044","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1203475418811335","article-title":"Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies","volume":"23","author":"Papp","year":"2019","journal-title":"J Cutan Med Surg"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:19:23Z","timestamp":1760033963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0738081X21001085"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.05.027","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}